Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Ovarian Neoplasms 799Uterine Cervical Neoplasms 537Endometrial Neoplasms 459Breast Neoplasms 221Fallopian Tube Neoplasms 198Colorectal Neoplasms 179Carcinoma, Non-Small-Cell Lung 163Neoplasms 137Stomach Neoplasms 127Pancreatic Neoplasms 118Prostatic Neoplasms 107Neoplasm Metastasis 107Melanoma 107Lung Neoplasms 103Carcinoma, Ovarian Epithelial 92Triple Negative Breast Neoplasms 91Squamous Cell Carcinoma of Head and Neck 82Esophageal Neoplasms 77Head and Neck Neoplasms 75Carcinoma, Renal Cell 75Urinary Bladder Neoplasms 74Uterine Neoplasms 66Vulvar Neoplasms 64Colonic Neoplasms 59Peritoneal Neoplasms 58Carcinoma, Hepatocellular 58Uterine Cervical Dysplasia 57Sarcoma 52Carcinoma, Transitional Cell 48Papillomavirus Infections 47

Interventions

sodium thiosulfate 1Oxaliplatin 1Mitomycin 1Fluorouracil 1Doxorubicin 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Necrosis × Gynecologic × 1 year × Clear all
NCT04847063 2026-04-14

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
60 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Gastrointestinal Neoplasms, Necrosis, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡